Li Q - Search Results

1

Nigericin Boosts Anti-Tumor Immune Response via Inducing Pyroptosis in Triple-Negative Breast Cancer.

Wu L, Bai S, Huang J, Cui G, Li Q, Wang J, Du X, Fu W, Li C, Wei W, Lin H, Luo ML. Wu L, et al. Among authors: li c, li q. Cancers (Basel). 2023 Jun 16;15(12):3221. doi: 10.3390/cancers15123221. Cancers (Basel). 2023. PMID: 37370831 Free PMC article.

2

Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer.

Li Q, Qin T, Bi Z, Hong H, Ding L, Chen J, Wu W, Lin X, Fu W, Zheng F, Yao Y, Luo ML, Saw PE, Wulf GM, Xu X, Song E, Yao H, Hu H. Li Q, et al. Nat Commun. 2020 Mar 19;11(1):1456. doi: 10.1038/s41467-020-15308-7. Nat Commun. 2020. PMID: 32193458 Free PMC article.

3

TSPAN8 serves as a prognostic marker involving Akt/MAPK pathway in nasopharyngeal carcinoma.

Lin X, Bi Z, Hu Q, Li Q, Liu J, Luo ML, Xiang Y, Yao H. Lin X, et al. Among authors: li q. Ann Transl Med. 2019 Sep;7(18):470. doi: 10.21037/atm.2019.08.02. Ann Transl Med. 2019. PMID: 31700906 Free PMC article.

4

Nanoparticles (NPs)-Meditated LncRNA AFAP1-AS1 Silencing to Block Wnt/β-Catenin Signaling Pathway for Synergistic Reversal of Radioresistance and Effective Cancer Radiotherapy.

Bi Z, Li Q, Dinglin X, Xu Y, You K, Hong H, Hu Q, Zhang W, Li C, Tan Y, Xie N, Ren W, Li C, Liu Y, Hu H, Xu X, Yao H. Bi Z, et al. Among authors: li c, li q. Adv Sci (Weinh). 2020 Aug 5;7(18):2000915. doi: 10.1002/advs.202000915. eCollection 2020 Sep. Adv Sci (Weinh). 2020. PMID: 32999837 Free PMC article.

5

Novel blood-based tumor mutation algorithm and nomogram predict survival of immune checkpoint inhibitor in non-small-cell lung cancer: Results from two multicenter, randomized clinical trials.

Yu Y, Chen Y, Li A, Ou Q, Li Q, Gu Y, Lin D, Zhang W, Wang J, Tang X, Li Z, Hu H, Yao H. Yu Y, et al. Among authors: li z, li a, li q. Clin Transl Med. 2020 Jun;10(2):e53. doi: 10.1002/ctm2.53. Epub 2020 Jun 5. Clin Transl Med. 2020. PMID: 32508050 Free PMC article. No abstract available.

6

LncRNA Uc003xsl.1-Mediated Activation of the NFκB/IL8 Axis Promotes Progression of Triple-Negative Breast Cancer.

Xu Y, Ren W, Li Q, Duan C, Lin X, Bi Z, You K, Hu Q, Xie N, Yu Y, Xu X, Hu H, Yao H. Xu Y, et al. Among authors: li q. Cancer Res. 2022 Feb 15;82(4):556-570. doi: 10.1158/0008-5472.CAN-21-1446. Cancer Res. 2022. PMID: 34965935 Free PMC article.

7

Long Non-Coding RNA MNX1-AS1 Promotes Progression of Triple Negative Breast Cancer by Enhancing Phosphorylation of Stat3.

Li J, Li Q, Li D, Shen Z, Zhang K, Bi Z, Li Y. Li J, et al. Among authors: li d, li y, li q. Front Oncol. 2020 Jul 10;10:1108. doi: 10.3389/fonc.2020.01108. eCollection 2020. Front Oncol. 2020. PMID: 32754442 Free PMC article.

8

Enhancer-Driven lncRNA BDNF-AS Induces Endocrine Resistance and Malignant Progression of Breast Cancer through the RNH1/TRIM21/mTOR Cascade.

Lin X, Dinglin X, Cao S, Zheng S, Wu C, Chen W, Li Q, Hu Q, Zheng F, Wu Z, Lin DC, Yao Y, Xu X, Xie Z, Liu Q, Yao H, Hu H. Lin X, et al. Among authors: li q. Cell Rep. 2020 Jun 9;31(10):107753. doi: 10.1016/j.celrep.2020.107753. Cell Rep. 2020. PMID: 32521278 Free article.

9

miR-668 enhances the radioresistance of human breast cancer cell by targeting IκBα.

Luo M, Ding L, Li Q, Yao H. Luo M, et al. Among authors: li q. Breast Cancer. 2017 Sep;24(5):673-682. doi: 10.1007/s12282-017-0756-1. Epub 2017 Jan 30. Breast Cancer. 2017. PMID: 28138801

10

The global patent landscape of HER2-targeted biologics.

Li Q, Xu J, Sun Q, Zhang Z, Hu Y, Yao H. Li Q, et al. Nat Biotechnol. 2023 Jun;41(6):756-764. doi: 10.1038/s41587-023-01814-8. Nat Biotechnol. 2023. PMID: 37316732 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60,930 results

Search Page